Rockwell Medical, Inc. (RMTI)
NASDAQ · Healthcare
Rockwell Medical, Inc. EBITDA 2017–2025
Rockwell Medical, Inc. annual/quarterly ebitda history and growth rate from 2017 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Rockwell Medical, Inc. ebitda for the quarter ending March 31, 2026 was -969000, a 18.03% increase year-over-year.
- Rockwell Medical, Inc. ebitda for the twelve months ending March 31, 2026 was -3.8 M, a 87.19% decrease year-over-year.
- Rockwell Medical, Inc. annual ebitda for 2025 was -2.5 M, a 189.63% decrease from 2024.
- Rockwell Medical, Inc. annual ebitda for 2024 was 2.8 M, a 153.35% decrease from 2023.
- Rockwell Medical, Inc. annual ebitda for 2023 was -5.2 M, a 67.75% decrease from 2022.
- Rockwell Medical, Inc. annual ebitda for 2022 was -16.2 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Rockwell Medical, Inc. EBITDA — FAQ
Rockwell Medical, Inc. (RMTI) ebitda over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RMTI's ebitda history?
The chart and table above show Rockwell Medical, Inc.'s ebitda by year and by quarter, including the growth rate.